Ketorolac Tromethamine

Specifications

74103-07-4CAS Number

620-545-3EC Number

2-amino-2-(hydroxymethyl)propane-1,3-diol;5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acidIUPAC Name

C19H24N2O6Chemical Formula

376.4 g/molMolecular Weight

Ketorolac tromethamine; 74103-07-4; Toradol; Acular; Ketorolac trometamol; Acuvail; Lixidol; Dolac; Acular LS; SPRIX; Tarasyn; Acular Preservative Free; DTXSID0045597; NSC-758637; 4EVE5946BQ; DTXCID301476271; OMIDRIA COMPONENT KETOROLAC TROMETHAMINE; CHEBI:6130; Toronova SUIK; Acunivive 15; Acunivive 30; Acunivive 60; Toronova II SUIK; Ketotolac Tromethamine; RefChem:55434; 1H-Pyrrolizine-1-carboxylic acid, 5-benzoyl-2,3-dihydro, (+-)-, compound with 2-amino-2-(hydroxymethyl)-1,3-propanediol(1:1); Ketorolac tris salt; Ketorolac tromethamine salt; Ketorolac (tromethamine salt); Acular PF; 2-amino-2-(hydroxymethyl)propane-1,3-diol 5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylate; MFCD00887595; Ketrolac.Tromethamine Salt; Syntex; Toradol (TN); M02042; 1H-Pyrrolizine-1-carboxylic acid, 5-benzoyl-2,3-dihydro-, compd. with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1); 2-amino-2-(hydroxymethyl)propane-1,3-diol;5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid; Godek; Ketorolac Tromethamine;Ketorolac tris salt;RS37619 tromethamine salt; SMR000058461; Ketorolac (Toradol); Ketorolac tromethamine [USAN]; Tromethamine ketorolac; SR-01000075948; NCGC00185990-01; RS-37619; UNII-4EVE5946BQ; Ketanov; Ketorol; Toratex; Droal; Tora-Dol; NCGC00017135-01; Ketorolac tromethamine [USAN:USP]; Acular (TN); CAS-74103-07-4; BPPC; Spectrum_001578; CPD000058461; Ketorolac trometamol CRS; Prestwick0_000929; Prestwick1_000929; Prestwick2_000929; Prestwick3_000929; Spectrum2_001598; Spectrum3_001975; Spectrum4_000215; Spectrum5_001273; SCHEMBL5036; Lopac0_000676; BSPBio_000838; BSPBio_003575; KBioGR_000849; KBioSS_002058; (+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid, compound with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1); 2-amino-2-(hydroxymethyl)propane-1,3-diol; 5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid; Ketorolac tromethamine (USP); MLS000069689; MLS001401455; MLS002222310; DivK1c_000836; SPECTRUM1503925; SPBio_001596; SPBio_003017; BPBio1_000922; orb1224098; orb1309385; CHEMBL1201124; HMS502J18; HY-B0138R; KBio1_000836; KBio2_002058; KBio2_004626; KBio2_007194; KBio3_002953; ROX-828; ROX-888; NINDS_000836; HMS1570J20; HMS1922K22; HMS2051P06; HMS2093M05; HMS2097J20; HMS2235N13; HMS3262G13; HMS3373M06; HMS3393P06; HMS3655E15; HMS3714J20; HMS5085M13; KETOROLAC TROMETAMOL [JAN]; Pharmakon1600-01503925; HY-B0138; Tox21_110795; Tox21_113519; Tox21_500676; CCG-39376; KETOROLAC TROMETAMOL [MART.]; MSK163439; NSC758637; s5698; KETOROLAC TROMETHAMINE [VANDF]; AKOS024386301; Tox21_110795_1; CCG-101006; CS-1933; FK27530; KETOROLAC TROMETHAMINE [USP-RS]; KETOROLAC TROMETHAMINE [WHO-DD]; LP00676; NC00256; NSC 758637; IDI1_000836; Ketorolac (+/-)-form tromethamine salt; NCGC00016159-02; NCGC00016159-03; NCGC00016159-04; NCGC00094036-01; NCGC00094036-02; NCGC00094036-03; NCGC00185990-04; NCGC00261361-01; 1H-Pyrrolizine-1-carboxylic acid, 5-benzoyl-2,3-dihydro, (+-)-, compound with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1); AS-15193; Ketorolac (tromethamine salt) (Standard); Ketorolac tris salt;Ketorolac Tromethamine; Ketorolac tris salt, >=99%, crystalline; KETOROLAC TROMETAMOL [EP MONOGRAPH]; DB-055837; KETOROLAC TROMETHAMINE [ORANGE BOOK]; EU-0100676; K1978; ST51037313; SW197293-4; KETOROLAC TROMETHAMINE [USP MONOGRAPH]; D00813; K 1136; Ketorolac trometamol for peak identification CRS; SR-01000946595; SR-01000075948-1; SR-01000075948-6; SR-01000075948-8; SR-01000946595-1; KETOROLAC (+/-)-FORM TROMETHAMINE SALT [MI]; Q27107089; F0001-2390; Ketorolac Trometamol 1.0 mg/ml in Methanol (as free acid); Ketorolac trometamol, European Pharmacopoeia (EP) Reference Standard; (+/-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid tris salt; Ketorolac Tromethamine, United States Pharmacopeia (USP) Reference Standard; Ketorolac trometamol for peak identification, European Pharmacopoeia (EP) Reference Standard; Ketorolac Tromethamine, Pharmaceutical Secondary Standard; Certified Reference Material; (+/-)-5-BENZOYL-2,3-DIHYDRO-1H-PYRROLIZINE-1-CARBOXYLIC ACID, COMPOUND WITH 2-AMINO-2-(HYDROXYMETHYL)-1,3-PROPANEDIOL (1:1); 1H-PYRROLIZINE-1-1H-PYRROLIZINE-1-CARBOXYLIC ACID, 5-BENZOYL-2,3-DIHYDRO, (+/-)-, COMPOUND WITH 2-AMINO-2-(HYDROXYMETHYL)-1,3-PROPANEDIOL (1:1); 2-AMINO-2-(HYDROXYMETHYL)PROPANE-1,3-DIOL (1RS)-5-BENZOYL-2,3-DIHYDRO-1H-PYRROLIZINE-1-CARBOXYLATE; 5-(phenylcarbonyl)-2,3-dihydropyrrolizinecarboxylic acid, 2-amino-2-(hydroxyme thyl)propane-1,3-diol; 5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid--2-amino-2-(hydroxymethyl)propane-1,3-diol (1/1)Synonyms